Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 12, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merus N.V.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Aclaris Therapeutics, Inc.
| 4.51K |
—
|
—
| +13.18% | 38.7K |
Jun 1 - Jun 2
| |||||||
Aclaris Therapeutics, Inc.
| 3.36K |
—
|
—
| +10.88% | 34.2K |
Jun 2 - Jun 3
| |||||||
Merus N.V.
|
0
|
—
|
—
|
—
|
0
|
May 31
| |||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 3
| |||||||
Merus N.V.
|
0
|
—
|
—
|
—
|
0
|
May 28
| |||||||
Aclaris Therapeutics, Inc.
| 14.63K |
$18.34 | $268,298.24 | +90.27% | 30.84K |
Feb 2
| |||||||
Merus N.V.
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Aclaris Therapeutics, Inc.
| 7.33K |
—
|
—
| +82.62% | 16.21K |
Jun 4 - Jun 6
| |||||||
Aclaris Therapeutics, Inc.
| 8.88K |
—
|
—
|
∞
| 8.88K |
Mar 2
| |||||||
Merus N.V.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Spark Therapeutics, Inc.
| -521.47K |
$114.50 | -$59,708,658.50 | -100.00% |
0
|
Dec 17
| |||||||
Nextcure, Inc.
| 150K |
$36.75 | $5,512,500.00 | +5.95% | 2.67M |
Nov 15
| |||||||
Galera Therapeutics, Inc.
| 3.08M |
$12.00 |
—
|
∞
| 3.08M |
Nov 12
| |||||||
Galera Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Spark Therapeutics, Inc.
| 1.5K |
—
|
—
| +3.88% | 40.2K |
May 30
| |||||||
Nextcure, Inc.
| 2.52M |
$15.00 |
—
|
∞
| 2.52M |
May 13
| |||||||
Nextcure, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Spark Therapeutics, Inc.
| 37.2K |
$3.45 | $128,350.35 | +2,480.20% | 38.7K |
Jan 4
| |||||||
Aclaris Therapeutics, Inc.
| 372.09K |
$10.75 | $3,999,999.75 | +24.17% | 1.91M |
Oct 22
| |||||||
Entasis Therapeutics Holdings Inc.
| 1.16M |
$15.00 |
—
| +300.87% | 1.54M |
Sep 28
| |||||||
Entasis Therapeutics Holdings Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Principia Biopharma Inc.
| 2.04M |
$17.00 |
—
|
∞
| 2.04M |
Sep 18
| |||||||
Principia Biopharma Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 7
| |||||||
Spark Therapeutics, Inc.
| 1.5K |
—
|
—
|
∞
| 1.5K |
May 30 - May 31
| |||||||
Iterum Therapeutics Plc
| 1.73M |
$13.00 |
—
|
∞
| 1.73M |
May 30
| |||||||
Iterum Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Spark Therapeutics, Inc.
| -211.86K |
$70.15 | -$14,861,992.86 | -30.57% | 481.27K |
Jul 24
|
Scheduled
| ||||||
Spark Therapeutics, Inc.
| -6.30K |
$65.00 | -$409,630.00 | -0.90% | 693.13K |
Jun 20 - Jun 21
|
Scheduled
| ||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Spark Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 31
| |||||||
Spark Therapeutics, Inc.
| -15.28K |
$65.01 | -$993,027.75 | -2.14% | 699.43K |
Mar 2
|
Scheduled
| ||||||
Spark Therapeutics, Inc.
| -84.65K |
$65.02 | -$5,504,028.38 | -10.59% | 714.71K |
Feb 27 - Mar 1
|
Scheduled
| ||||||
Spark Therapeutics, Inc.
| -7.54K |
$65.01 | -$489,850.35 | -0.93% | 799.36K |
Feb 17
|
Scheduled
| ||||||
Spark Therapeutics, Inc.
| -35.35K |
$65.03 | -$2,298,547.91 | -4.20% | 806.89K |
Feb 14 - Feb 16
|
Scheduled
| ||||||
Spark Therapeutics, Inc.
| -37.41K |
$65.06 | -$2,433,959.66 | -4.25% | 842.24K |
Feb 9
|
Scheduled
| ||||||
Spark Therapeutics, Inc.
| -25.33K |
$65.06 | -$1,648,129.56 | -2.80% | 879.65K |
Feb 3 - Feb 7
|
Scheduled
| ||||||
Aclaris Therapeutics, Inc.
| -750.00K |
$28.25 | -$21,188,325.00 | -32.76% | 1.54M |
Jan 10
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.